TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BiolacUm AB
Closing information (x1000 DKK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
256
|
404 | |
| Financial expenses |
0
|
1,679 | |
| Earnings before taxes |
1,403
|
-1,511 | |
| EBITDA |
99
|
165 | |
| Total assets |
4,796
|
3,550 | |
| Current assets |
418
|
402 | |
| Current liabilities |
40
|
33 | |
| Equity capital |
4,646
|
3,379 | |
| - share capital |
65
|
67 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
96.9%
|
95.2% | |
| Turnover per employee |
256
|
404 | |
| Profit as a percentage of turnover |
548.0%
|
-374.0% | |
| Return on assets (ROA) |
29.3%
|
4.7% | |
| Current ratio |
1045.0%
|
1218.2% | |
| Return on equity (ROE) |
30.2%
|
-44.7% | |
| Change turnover |
-134
|
-157 | |
| Change turnover % |
-5%
|
-34%
|
-28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.